Explainers

The Yoga Mat Chemical Is Finally Under Federal Review in the US

Azodicarbonamide has been in American bread for decades and off European ingredient lists the whole time. In May the FDA opened its first real reassessment. Here's what the review can and can't settle.

If you have heard of azodicarbonamide at all, you probably know it by its nickname. The yoga mat chemical. It’s the additive a food blogger went after in 2014, pointing out that the same compound puffing up your gym mat and the foam in your sneaker soles was also whitening the flour in a lot of American sandwich bread. Subway pulled it within weeks. The Environmental Working Group counted it on the labels of nearly 500 products. Then, as these things go, the outrage cooled and the ingredient stayed.

Twelve years later it’s back, and this time it’s the regulator’s move. In May 2026 the FDA opened a formal post-market review of azodicarbonamide, one of the first two chemicals it picked up under a new systematic process for re-examining additives already in the food supply. The comment window closed on July 13. So this is a good moment to sort out what’s actually known, because the “yoga mat” line is both the reason people care and the reason the story usually gets told badly.

Let me walk through it.

What ADA does, and why it’s in bread and not much else

Azodicarbonamide, ADA for short, does two jobs in a bakery. It bleaches flour fast, turning freshly milled, faintly yellow flour the bright white American shoppers came to expect. And it works as a dough conditioner, strengthening the gluten network so industrial dough holds up to high-speed mixing and machine handling. The FDA allows it in flour and as a dough strengthener at up to 45 parts per million. That ceiling has been on the books since the 1960s.

It really is the same molecule used to foam plastics. That fact is true and also close to meaningless as a safety argument. Salt is used to de-ice roads; caffeine is used as a pesticide. What a compound does in an unrelated industrial setting tells you nothing about whether a trace of it in bread is harmful. So set the yoga mat aside for a minute. The real questions are narrower, and more interesting: what happens to ADA when you bake it, and what happens to the people who handle it.

The thing that actually worries regulators: semicarbazide

When dough containing ADA hits oven heat, the ADA breaks down. Most of it becomes biurea, which reads as inert. But a small fraction converts to semicarbazide, usually shortened to SEM. And semicarbazide is the compound that has done the real regulatory work here, on both sides of the Atlantic.

SEM has caused tumors and other effects in animal studies at high doses, and it carries genotoxicity flags, meaning it’s the kind of compound scientists don’t like to assume has a safe threshold. Europe ran into it from a different direction than bread. SEM was turning up in baby food, and the trail led to ADA used as a blowing agent in the plastic gaskets that seal glass jars. That prompted EFSA to look hard at the compound, and the EU moved to stop ADA’s use as a blowing agent in food-contact plastics back in 2005.

Here’s the honest part. The levels of semicarbazide involved are very low, and European risk assessors were careful not to overclaim. The concern was precautionary: a genotoxic breakdown product, small children as the exposed group, and no strong reason to accept even a small risk when the additive was replaceable. That’s a defensible call. It is not the same thing as saying your bagel is poisoning you, and anyone who tells you Europe “proved ADA causes cancer” is filling in a certainty that the science doesn’t carry.

The clearer harm is to workers, not eaters

If there’s a well-documented danger in the ADA story, it’s occupational. Inhaling ADA dust can sensitize the airways, and case reports going back to around 1980 describe asthma and allergic reactions in bakery and plastics workers exposed to it. Once someone is sensitized, even small later exposures can set off a serious asthmatic response. The World Health Organization’s food additive reviewers flagged the respiratory issue for handlers, and in 2012 the EU added ADA to the REACH candidate list of Substances of Very High Concern specifically for its respiratory sensitizing properties.

That’s a real, characterized hazard. It also mostly lands on the person shoveling the powder, not the person eating the roll, and keeping those two exposures separate is exactly the kind of distinction that gets lost when a chemical becomes a meme.

So why is it “banned in Europe”?

Because Europe runs its food additives on a positive list. Under Regulation (EC) No 1333/2008, an additive is only legal if it has been specifically evaluated and authorized for a defined use. Azodicarbonamide isn’t on that list for food. It once had a European additive number, E927a, but it is not permitted as a flour treatment agent in the EU today. So it’s “banned” in the practical sense that you can’t use it, though the mechanism is less a dramatic prohibition than a default: nobody made the case to authorize it, and the SEM question gave regulators no appetite to.

The United States runs the opposite way. ADA was cleared decades ago and has stayed cleared, because the American system tends to leave approved additives in place unless a review actively removes them. For most of the last sixty years, there was no such review. That asymmetry, not a settled science fight, is the actual gap between the two continents. Europe’s burden of proof sits on the company wanting to use the additive. America’s has effectively sat on whoever wants to take it away. It’s the same structural story behind potassium bromate, the other flour treatment Europe never allowed and the US never pulled.

What changed in 2026

For a long time the FDA didn’t have a routine way to revisit old approvals. Now it says it does. In May 2026 the agency finalized a post-market assessment program, published a method for prioritizing which chemicals to look at first, and named its opening pair: azodicarbonamide and BHT, the preservative. For ADA, the FDA issued a Request for Information under docket FDA-2026-N-2526, asking industry and the public for current use levels, dietary exposure estimates, and safety data. Comments were due July 13, 2026.

A small but telling detail: when the BHT comment period was running, the agency reopened it to allow more time. It did not do the same for ADA. The FDA reported no requests for an extension, and the ADA record closed on schedule. Read that however you like. It could mean the science is considered more settled, or simply that fewer parties felt they had new data to add.

What the review can do is force the question the US never formally asked: is ADA still safe under its current, decades-old conditions of use, judged against today’s understanding of semicarbazide and worker exposure? What it can’t do, at least not quickly, is produce a ban. A Request for Information is the first step of a long process, not a verdict. If you want a realistic timeline, think in years, and expect industry pushback framed around the low SEM levels and the additive’s functional role.

What this means if you’re standing in the bread aisle

Keep it in proportion. The case for worrying about ADA in your own diet is modest and mostly precautionary, and the “yoga mat” framing oversells it. Bread is not going to be the additive that decides your health. As I keep coming back to on this site, the reasons a lot of people feel better eating in Europe have more to do with portions, walking, and food culture than with any single compound on a label, and bread specifically is a case where the honest answer is complicated.

If you’d rather skip ADA anyway, that’s easy and reasonable. It has to be declared on the label, listed as azodicarbonamide, and plenty of American bakeries already leave it out. Reading for it costs you nothing.

The more interesting thing to watch isn’t your loaf. It’s whether the FDA’s new review process actually has teeth, or whether ADA becomes a test case for how the agency handles the long backlog of additives Europe reassessed years ago. This is the first real look in sixty years. What the FDA does with it will tell us a lot.

Sources